Загрузка...
What autoantibody tests should become widely available to help scleroderma diagnosis and management?
Anti-Th/To autoantibodies have been recognized as serological markers of systemic sclerosis (SSc) for more than 20 years. However, validated immunoassay kits to test this specificity have not been commercially available. SSc autoantibodies are basically mutually exclusive and are associated with a c...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978467/ https://ncbi.nlm.nih.gov/pubmed/23856077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4241 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|